下一个十年的疫苗:社会和科学挑战
E Richard Moxon1, Claire-Anne Siegrist
1University of Oxford Department of Paediatrics, John Radcliffe Hospital, Oxford, UK.
Lancet (London, England)
|June 14, 2011
概括
未来的疫苗将扩展到病毒和细菌疾病之外,包括寄生虫和真菌感染. 开发这些新型免疫需要更深入地了解免疫学,并解决公众对疫苗安全性和有效性的信任问题.
科学领域:
- 免疫学和疫苗开发
- 微生物学 微生物学
- 公共卫生 公共卫生
背景情况:
- 疫苗通过预防微生物疾病显著改善了全球健康状况.
- 科学进步为针对病毒,细菌,寄生虫和真菌疾病的新疫苗提供了机会.
- 公众对疫苗安全和发展组织的信心和信任对于实现公共卫生收益至关重要.
研究的目的:
- 探索疫苗开发的未来机遇和挑战.
- 突出需要创新的方法来打击具有高病原体变异性的疾病.
- 强调了解免疫学挑战对于设计有效和安全疫苗的重要性.
主要方法:
- 审查过去的疫苗开发策略.
- 分析当前的科学和技术进步.
- 考虑免疫学挑战,宿主遗传和环境因素.
主要成果:
- 未来的疫苗需要解决艾滋病毒和疟疾等疾病,在这些疾病中,自然免疫力通常是无效的.
- 针对弱势群体 (老年人,免疫受损者) 开发疫苗是未来的一个关键方向.
- 个性化的方法和合理的辅助剂设计对于新型疫苗开发至关重要.
结论:
- 存在重要的科学机会来扩大疫苗组合.
- 克服与病原体变异性和公众信任相关的挑战是必要的.
- 更深入地了解免疫学对于开发下一代安全有效的疫苗至关重要.
相关概念视频
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccinations
Overview
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Human Virome
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible only with...


